| Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Palladon Inject 50 mg, Injektions-/Infusionslösung | | 59225 | | 04 | | Palladon Inject 50 mg | | Injektions-/Infusionslösung | | N02AA03 | | Hydromorphon | | 18.12.2009 | | |
| | Composition | | hydromorphoni hydrochloridum 50 mg corresp. hydromorphonum 44.33 mg, natrii citras dihydricus, acidum citricum, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.92 mg. | | Packungsbestandteile | | Solution pour perfusion | | | | | | | | Principe actif | Concentr. |
|---|
| Hydromorphon Hydrochloride | 50 mg/ml correspond Hydromorphon 44.33 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Hydromorphon Hydrochloride | 50 mg |
| | | | Agents auxilliaires |
|---|
| Acide Citrique | | Acidum Hydrochloridum | | Sodium Chlorure | | Natrii Citras Dihydricus | | Sodium Hydroxide |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 007 | 5 ampoule(s) | 179.94 | 212.10 | A+ | LS | Oui | | 008 | 10 ampoule(s) | DDP | DDP | A+ | | Oui |
|
|
